These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31240316)

  • 1. Species identification, antifungal susceptibility, and clinical feature association of Aspergillus section Nigri isolates from the lower respiratory tract.
    Takeda K; Suzuki J; Watanabe A; Matsuki M; Higa K; Inoue E; Akashi S; Shimada M; Kawashima M; Ohshima N; Fukami T; Masuda K; Yamane A; Tamura A; Nagai H; Matsui H; Tohma S; Kamei K
    Med Mycol; 2020 Apr; 58(3):310-314. PubMed ID: 31240316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species identification, antifungal susceptibility, and clinical feature association of Aspergillus section Nigri isolates from the lower respiratory tract.
    Takeda K; Suzuki J; Watanabe A; Matsuki M; Higa K; Inoue E; Akashi S; Shimada M; Kawashima M; Ohshima N; Fukami T; Masuda K; Yamane A; Tamura A; Nagai H; Matsui H; Tohma S; Kamei K
    Med Mycol; 2020 Apr; 58(3):E3. PubMed ID: 31384931
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug Sensitivity and Resistance Mechanism in Aspergillus Section
    Hashimoto A; Hagiwara D; Watanabe A; Yahiro M; Yikelamu A; Yaguchi T; Kamei K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607016
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
    Halvaeezadeh M; Jalaee GA; Fatahinia M; Mahmoudabadi AZ
    Microb Pathog; 2023 Aug; 181():106180. PubMed ID: 37257666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
    Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
    J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of
    Nargesi S; Jafarzadeh J; Najafzadeh MJ; Nouripour-Sisakht S; Haghani I; Abastabar M; Ilkit M; Hedayati MT
    J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451946
    [No Abstract]   [Full Text] [Related]  

  • 7. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.
    Wang HC; Hsieh MI; Choi PC; Wu WL; Wu CJ;
    Mycoses; 2023 Aug; 66(8):711-722. PubMed ID: 37186489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.
    Kamali Sarwestani Z; Hashemi SJ; Rezaie S; Gerami Shoar M; Mahmoudi S; Elahi M; Bahardoost M; Tajdini A; Abutalebian S; Daie Ghazvini R
    J Mycol Med; 2018 Jun; 28(2):279-284. PubMed ID: 29540288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.
    Toyotome T; Saito S; Koshizaki Y; Komatsu R; Matsuzawa T; Yaguchi T
    J Infect Chemother; 2020 Feb; 26(2):321-323. PubMed ID: 31564504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
    Jing R; Yang WH; Xiao M; Li Y; Zou GL; Wang CY; Li XW; Xu YC; Hsueh PR
    J Microbiol Immunol Infect; 2022 Apr; 55(2):282-290. PubMed ID: 33839057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112
    Carrara B; Richards R; Imbert S; Morio F; Sasso M; Zahr N; Normand AC; Le Pape P; Lachaud L; Ranque S; Maubon D; Piarroux R; Fekkar A
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312779
    [No Abstract]   [Full Text] [Related]  

  • 12. Discovery of Tolerance to Itraconazole in Japanese Isolates of Aspergillus Section Nigri, Aspergillus tubingensis and Aspergillus welwitschiae, by Microscopic Observation.
    Matsumoto Y; Suzuki M; Nihei H; Matsumoto S
    Med Mycol J; 2022; 63(3):65-69. PubMed ID: 36047184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Aspergillus tubingensis in a primary skin infection.
    Frías-De-León MG; Rosas-de Paz E; Arenas R; Atoche C; Duarte-Escalante E; Molina de Soschin D; Acosta-Altamirano G; Reyes-Montes MR
    J Mycol Med; 2018 Jun; 28(2):274-278. PubMed ID: 29551443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
    Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
    Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black aspergilli: A remaining challenge in fungal taxonomy?
    D'hooge E; Becker P; Stubbe D; Normand AC; Piarroux R; Hendrickx M
    Med Mycol; 2019 Aug; 57(6):773-780. PubMed ID: 30535052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into the Cyp51 Contribution to Azole Resistance in
    Pérez-Cantero A; López-Fernández L; Guarro J; Capilla J
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.
    Li Y; Wan Z; Liu W; Li R
    J Clin Microbiol; 2015 Feb; 53(2):702-5. PubMed ID: 25502526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
    Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
    Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
    J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
    Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Cuenca-Estrella M; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4514-7. PubMed ID: 19635955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.